March 22, 2017 7:21 PM ET

Life Sciences Tools and Services

Company Overview of NAMSA Medvance

Key Executives for NAMSA Medvance

NameBoard RelationshipsTitleAge
Janette Benaddi No RelationshipsChief Executive Officer--
Mary Wilkinson No RelationshipsDirector of Finance & Administration--
Sandra Welch No RelationshipsDirector of Global Clinical Operations--

NAMSA Medvance Board Members*

NameBoard RelationshipsPrimary CompanyAge
There is no Board Members data available.

NAMSA Medvance Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
309.1K
Bonus
225.7K
Total Short Term Compensation
392.6K
Total Value of Options
30.9M
Compensation as of Fiscal Year
NAMSA Medvance CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Drugdev Names George Masoura as VP of Business Development
March 21, 2017 11:59 AM ET
Agilent Technologies Hires Samraat “Sam” Raha as Senior Vice President of Strategy and Corporate Development
March 20, 2017 8:05 PM ET
Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
March 20, 2017 10:00 AM ET
Mission Therapeutics Appoints Anne Phelan as Senior Vice President, Head of Discovery Research, Effective 20 March 2017
March 20, 2017 9:00 AM ET
Cellink AB Appoints David Williams, Ali Khademhosseini, Erik Ingelsson and Rolf Classon to Advisory Board
March 17, 2017 2:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NAMSA Medvance, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.